Trials / Completed
CompletedNCT00562302
Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure
A Prospective, Randomized, Multi-centered Safety and Efficacy Evaluation of the Bio-Seal Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 339 (actual)
- Sponsor
- Angiotech Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
BS-1053 A Prospective Randomized Multi-Centered Safety and Efficacy Evaluation of the Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedures
Detailed description
This is a multi-centered, randomized trial in patients receiving lung biopsies. Patients will be randomized to either receive or not receive a Bio-Seal Biopsy Track Plug after a lung biopsy per standard hospital protocol. This study is designed to demonstrate safety and efficacy of the Bio-Seal Biopsy Track Plug in reducing pneumothorax rates post lung biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bio-Seal Plug | Deployment of the Bio-Seal plug in needle track |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2008-06-01
- Completion
- 2008-08-01
- First posted
- 2007-11-22
- Last updated
- 2013-03-27
- Results posted
- 2013-03-27
Locations
18 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00562302. Inclusion in this directory is not an endorsement.